Clinical Trial: A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Oligometastatic Renal Cell Carcinoma
Study Type: INTERVENTIONAL
Official Title: A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)
Brief Summary:
To learn if adding 1 year of therapy with pembrolizumab can help to continue to control RCC after radiation therapy.
Read more